2025

Publikationsliste med Link til abstract.

  • Nielsen SR, Gjela M, Stoico MP, Drewes AM, Olesen SS, Højlund K et al. Mild pancreatic fibrosis with preserved exocrine function and increased visceral adipose tissue in m.3243A>G carriers: A magnetic resonance imaging study. Molecular Genetics and Metabolism. 2025 dec.;146(4): 109282. doi: 10.1016/j.ymgme.2025.109282 PMID:41205342

  • Nielsen SR, Stoico MP, Liao D, Drewes AM, Pedersen IS, Frederiksen AL et al. Prolonged Gastrointestinal Transit Times and Dysmotility in m.3243A>G Mitochondrial Disease. Neurogastroenterology and Motility. 2025 dec.;37(12):e70092. Epub 2025. doi: 10.1111/nmo.70092 PMID:40468624
  • Al-Mashat H, Baddoo DR, Lundbye-Christensen S, Madsen PH, Pedersen IS, Krarup HB et al. Cell-Free DNA Hypermethylation in Patients with Acute Pancreatitis. International Journal of Molecular Sciences . 2025 nov. 6;26(21): 10792. doi: 10.3390/ijms262110792 PMID:41226826
  • Barnes DR, Tyrer JP, Dennis J, Leslie G, Bolla MK, Lush M et al. Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer. npj Genomic Medicine. 2025 nov. 20;10(1):73. doi: 10.1038/s41525-025-00529-w PMID:41266372

  • Stubbe B, Pedersen IS, Madsen PH, Krarup HB, Olesen SS, Thorlacius-Ussing O et al. A novel prediction model of mortality in chronic pancreatitis using clinical characteristics and gene promoter hypermethylation status. Scandinavian Journal of Gastroenterology. 2025 nov.;60(11):1140-1149. doi: 10.1080/00365521.2025.2554345 PMID:41226826
  • Jakobsen MZ, Torp EA, Issa II, Høholt H, Sønderkaer M, Madsen J et al. Evaluation of reference sample type for somatic variant calling in myeloid cancers. Annals of Hematology. 2025 nov.;104(11):6091–6095. doi: 10.1007/s00277-025-06699-y PMID:41123648
  • Adel Jensen L, Baekgaard CH, Larsen MB, Boonen SE, Bak Jylling AM, Hikmat Z et al. Preliminary evaluation of ShallowHRD performance compared to HRDetect in familial breast cancer tumors. Scientific Reports. 2025 aug. 11;15(1):29442. doi: 10.1038/s41598-025-14122-9 PMID:40790321
  • Kostov AM, Jensen MB, Ejlertsen B, Thomassen M, Rossing M, Pedersen IS et al. Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study. Breast Cancer Research and Treatment. 2025 jul.;212(2):309-323. doi: 10.1007/s10549-025-07726-2 PMID:40408052
  • Thomsen SH, Hjortshøj TD, Barbosa M, Laursen L, Larsen M, Hvidbjerg MS et al. Genetik i føtalmedicin. Ugeskrift for laeger. 2025 apr. 28;187:V12240853. doi: 10.61409/V12240853 PMID:40358077
  • Terp SK, Guldbrandsen K, Stoico MP, Mark LR, Frandsen AP, Dybkær K et al. Genome-Wide cfDNA Methylation Profiling Reveals Robust Hypermethylation Signatures in Ovarian Cancer. Cancers. 2025 jun. 17;17(12). doi: 10.3390/cancers17122026 PMID:40563675
  • Munch AK, Feldner ES, Bækgaard CH, Larsen MB, Slemming-Adamsen N, Boonen DS et al. Classification of Gene Variants in a Danish Population with Suspected Predisposition to Hereditary Breast and/or Ovarian Cancer. Cancers. 2025 jun. 1;17:1819. Epub 2025 maj. doi: 10.3390/cancers17111819 PMID:40507299

  • Nguyen HTT, Stoico MP, Le VQ, Thomsen JHD, Krarup KB, Kristjansen KA et al. Metabolic signature of COVID-19 progression: potential prognostic markers for severity and outcome. Metabolomics. 2025 maj 21;21(3):70. doi: 10.1007/s11306-025-02264-w PMID:40399692

  • Ebbesen F, Madsen PH, Rodrigo-Domingo M, Donneborg ML. Bilirubin isomers during LED phototherapy of hyperbilirubinemic neonates, blue-green (~478 nm) vs blue. Pediatric Research. 2025 apr.;97(5):1623–1628. 7444. Epub 2024 sep. 4. doi: 10.1038/s41390-024-03493-w PMID:39232092
  • Watson H, Jepsen P, Vilstrup H, Krarup H. Delta in Denmark: prevalence of hepatitis delta virus infection. Infectious Diseases. 2025 feb.;57(2):202-206. Epub 2024 dec. 17. doi: 10.1080/23744235.2024.2434887 PMID:39688885
  • Kostov AM, Jensen MB, Ejlertsen B, Thomassen M, Rossing CM, Pedersen IS et al. Germline BRCA testing in Denmark following invasive breast cancer: Progress since 2000. Acta Oncologica. 2025 jan. 28;64:147-155. doi: 10.2340/1651-226X.2025.42418 PMID:39876688:

  • Mapendano CK, Nøhr AK, Sønderkær M, Pagh A, Carus A, Lörincz T et al. Longer survival with precision medicine in late-stage cancer patients. ESMO Open. 2025 jan.;10(1):104089. 104089. Epub 2025 jan. 3. doi: 10.1016/j.esmoop.2024.104089 PMID:39754975
  • Hansen J, Mohamed R, Ilkjær L, Krøigård T, Sivasaravanaparan M, Stoico MP et al. Comparison of microglial cell population expansion in the Tg344-AD rat and APPSWE/PS1ΔE9 mouse model of Alzheimer's disease. Journal of Alzheimer's disease reports. 2025;9. doi: 10.1177/25424823251387517 PMID:41146729
  • Vogel I, Andreasen L, Balslev-Harder M, Becher N, Ernst A, Gadsbøll K, et al. Whole Genome Sequencing in Prenatal Diagnostics: The Danish Approach to Guideline Formation and Implementation Within Public Healthcare. Prenatal diagnosis [Internet]. 2025 Autumn;10.1002/pd.6780. PMID:40122702
  • Kølle IS, Hesthaven AS, Davidsen L, Hagn-Meincke R, Drewes AM, Pedersen IS et al. Diagnostic yield of second-line aetiological workup in patients with presumed idiopathic acute pancreatitis: a retrospective cohort study. Scandinavian Journal of Gastroenterology. 2025;60(5):485-493. doi: 10.1080/00365521.2025.2485135 PMID:40160120
  • Stubbe B, Stoico MP, Terp SK, Madsen PH, Lundbye-Christensen S, Hansen CP et al. Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma. Frontiers in Oncology. 2025;15:1568386. doi: 10.3389/fonc.2025.1568386 PMID:40492125

Kontakt

Opdateret